🇮🇪Ireland
16°C Partly Cloudy · Dublin
Live Updates
--:--:-- IST
Writer Login
Latest
A Global Milestone for Wellness: Chanelle McCoy Health Secures Historic Dual SFDA and European Novel Food Regulatory Approvals The Digital and Regulatory Frontier: Top 10 Technical and GMP Trends Shaping Pharma in 2026 Funding the Future: Inside the €75k Women TechEU and £10M Createch Grants for Startups and SMEs FDA Fires Warning Shot at Sanofi's Irish Plant Over Data Cover-Up and Altuviiio Quality Failings Top Universities in Ireland: Discover the Country's Leading Higher Education Institutions The Irish Startup Ecosystem: A Comprehensive Funding and Development Guide for Entrepreneurs Addiction Counsellors of Ireland Launch Strategic Plan 2026–2029 to Prepare for CORU Regulation Ireland Funds €426,000 Behavioral App for Alcohol Reduction Amid Record Treatment Demand A Global Milestone for Wellness: Chanelle McCoy Health Secures Historic Dual SFDA and European Novel Food Regulatory Approvals The Digital and Regulatory Frontier: Top 10 Technical and GMP Trends Shaping Pharma in 2026 Funding the Future: Inside the €75k Women TechEU and £10M Createch Grants for Startups and SMEs FDA Fires Warning Shot at Sanofi's Irish Plant Over Data Cover-Up and Altuviiio Quality Failings Top Universities in Ireland: Discover the Country's Leading Higher Education Institutions The Irish Startup Ecosystem: A Comprehensive Funding and Development Guide for Entrepreneurs Addiction Counsellors of Ireland Launch Strategic Plan 2026–2029 to Prepare for CORU Regulation Ireland Funds €426,000 Behavioral App for Alcohol Reduction Amid Record Treatment Demand
Markets · 15 min delay
NBI4,187.6▲ +1.14%
PFE28.42▼ -0.38%
AZN74.18▲ +0.81%
NVO103.55▲ +2.07%
ROG261.40▼ -0.55%
ABBV174.92▲ +0.29%
EUR/USD1.0842▼ -0.12%
ISEQ9,241.3▲ +0.62%
NBI4,187.6▲ +1.14%
PFE28.42▼ -0.38%
AZN74.18▲ +0.81%
NVO103.55▲ +2.07%
ROG261.40▼ -0.55%
ABBV174.92▲ +0.29%
EUR/USD1.0842▼ -0.12%
Updated 04 Jul 2026 · HPRA open data

Darunavir - Medicines in Ireland

17 authorised products containing Darunavir, from the HPRA register.

A B C D E F G H I J K L M N O P Q R S T U V W X Y Z 0–9
Showing 17 authorised medicines
MedicineActive substanceLicence holderStatus
Darunavir Clonmel 600 mg film-coated tablets
PA0126/299/002
Darunavir Clonmel Healthcare Ltd Marketed
Darunavir Clonmel 800 mg film-coated tablets
PA0126/299/003
Darunavir Clonmel Healthcare Ltd Marketed
Darunavir Krka 400 mg Film-coated tablet
EU/1/17/1249/001-004
Darunavir KRKA, d.d., Novo mesto
Darunavir Krka 600 mg Film-coated tablet
EU/1/17/1249/005-008
Darunavir KRKA, d.d., Novo mesto
Darunavir Krka 800 mg Film-coated tablet
EU/1/17/1249/009-010
Darunavir KRKA, d.d., Novo mesto
Darunavir Krka d.d.
EU/1/17/1248/001-004
Darunavir KRKA, d.d., Novo mesto
Darunavir Krka d.d.
EU/1/17/1248/005-008
Darunavir KRKA, d.d., Novo mesto
Darunavir Krka d.d.
EU/1/17/1248/009-010
Darunavir KRKA, d.d., Novo mesto
Darunavir Rowex 800 mg Film-coated tablets
PA0711/269/004
Darunavir Rowex Ltd Not marketed
Darunavir Viatris 150 mg film-coated tablets
EU/1/16/1140/006-011
Darunavir Viatris Limited
Darunavir Viatris 300 mg film-coated tablets
EU/1/16/1140/012-021
Darunavir Viatris Limited
Darunavir Viatris 400 mg film-coated tablets
EU/1/16/1140/022-029
Darunavir Viatris Limited
Darunavir Viatris 600mg film-coated tablets
EU/1/16/1140/030-038
Darunavir Viatris Limited
Darunavir Viatris 75 mg film-coated tablets
EU/1/16/1140/001-005
Darunavir Viatris Limited
Darunavir Viatris 800 mg film-coated tablets
EU/1/16/1140/039-045
Darunavir Viatris Limited
Prezista
EU/1/06/380/003
Darunavir Janssen-Cilag International NV
REZOLSTA 800 mg/150 mg film-coated tablets
EU/1/14/967/001
Darunavir, Cobicistat Janssen-Cilag International NV
Cite this database

Priya Life Science (2026). Irish Medicines Database. Available at: https://priyalifescience.com/medicines (Accessed: 5 July 2026).

Data: Health Products Regulatory Authority (HPRA) open dataset (“Authorised or Transfer Pending Products”), licensed CC BY 4.0, refreshed daily. Regulatory information only — not medical advice.